CRNA of the year

Lisa Deppen

Lisa Deppen has been awarded the 2023 CRNA of the Year award by the Pennsylvania Association of Nurse Anesthetists! This prestigious award is presented to a CRNA who practices in the state of Pennsylvania and demonstrates the core values of advocacy, leadership, and integrity. The CRNA of the year is peer-nominated by CRNAs in Pennsylvania. Lisa has provided top notch care for thousands of patients throughout her extensive career, and helped train numerous CRNAs as a clinical instructor at Crozer Chester Medical Center for 20 years. She joined United Anesthesia Services in 2016 and quickly became lead CRNA at Bryn Mawr Hospital where she’s mentored CRNAs and supported the anesthesiology team for the past 5 years.

Fellow of the American Society of Anesthesiologists

Corey Herman

Dr. Corey Herman has been appointed Fellow of the American Society of Anesthesiologists (FASA), a prestigious distinction recognizing ASA members who demonstrate the highest standards in professionalism/leadership, advocacy for the profession, patient safety, and commitment to the specialty. This honor sets designees apart from their peers and highlights a physician’s commitment to advancing the practice and securing the future of anesthesiology.

After Graduating from Sackler School of Medicine at Tel Aviv University, Dr. Herman completed his anesthesia residency at Thomas Jefferson University Hospital where he was given the Joseph L. Seltzer award for academic achievement in residency. He then completed his fellowship in adult cardiovascular and thoracic anesthesia at Weill Cornell Medical Center and subsequently became board certified in advanced perioperative echocardiography. Having authored multiple publications in peer-reviewed journals, he has also presented at many local, regional, and national meetings and conferences.

Since joining United Anesthesia Services in 2018, he has been an integral member of the Main Line Health’s Lankenau Medical Center cardiac anesthesia team, provides leadership on the operating committee, oversees the anesthesia quality metrics initiative at MLH, and liaises for Lankenau for EPIC, blood bank, labs, surgical site infection reduction, and supply chain management.

Director of Anesthesia Services, Jefferson Surgery Center at The Navy Yard

Armen Voskeridjian

Dr. Armen Voskeridjian M.D. grew up in Queens, New York City, and graduated from The Bronx High School of Science. He earned his Bachelor of Arts in Biochemistry from New York University. After receiving his Medical Doctorate from The State University of New York - Brooklyn, he completed a residency in Internal Medicine at Staten Island University Hospital and is Board Certified in Internal Medicine.

Dr. Voskeridjian completed his Anesthesia residency at New York Presbyterian Hospitals and is also Board Certified in Anesthesiology. After a brief time in private practice, Dr. Voskeridjian moved to Philadelphia to be closer to his family and was an Attending Anesthesiologist at Albert Einstein Medical Center for 12 years, teaching and supervising Certified and Student Registered Nurse Anesthetists, as well as being an Associate of Clinical Operations. It was during this time that Dr. Voskeridjian began training in Ultrasound Guided Regional Anesthesia.

Switching gears from a high volume, high acuity Level I Trauma center in North Philadelphia, Dr. Voskeridjian began working for United Anesthesia Services in 2014 as an Attending Anesthesiologist. Since January 2020, as the Director of Anesthesia Services for Jefferson Surgery Center at the Navy Yard, Dr. Voskeridjian has been integral in creating a "Minimal to No Opioid" environment at The Navy Yard. Combined with research and ingenuity, he is bringing the goal of narcotic-free orthopedic surgery closer to reality. He is achieving this goal with outpatient shoulder, clavicle, humerus, elbow, ACL, knee, and foot/ankle surgery. Using ultrasound-guided regional anesthesia with medications administered in the nerve blocks, Dr. Voskeridjian is able to get up to 7 days of pain control with minimal to no narcotic use. These results are currently being studied in clinical trials so that they may be shared with other surgery centers around the United States and the world. This ground-brea king work is featured in his article published in The Philadelphia Inquirer, September 13, 2023.